Making the Business Case for Continuous Manufacturing in the Pharmaceutical Industry
- At: 2017 FIP Congress in Stockholm (Sweden)
- Type: Presentation
- By: HARRINGTON, Tomás (Institute for Manufacturing, University of Cambridge, Engineering, Cambridge, United Kingdom)
- Co-author(s): Tomás Harrington: Engineering, Institute for Manufacturing, University of Cambridge, Cambridge, United Kingdom
This research explores future value network configurations which, when aligned with disruptive shifts in technology (process and digital), may enable alternative routes to medicines production and the delivery of additional value to ‘end-users’, i.e. patients and health care providers.
Despite reported benefits in the academic literature, current.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.